RecruitingPHASE1, PHASE2NCT07346144

Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma

Studying Glioblastoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Trogenix ltd
Intervention
TGX-007(drug)
Enrollment
68 enrolled
Eligibility
18-70 years · All sexes
Timeline
20262033

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07346144 on ClinicalTrials.gov

Other trials for Glioblastoma

Additional recruiting or active studies for the same condition.

See all trials for Glioblastoma

← Back to all trials